Anti-EPGN/ ALGV3072/ EPG functional antibody

Anti-EPGN/ ALGV3072/ EPG functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to EPGN/EPGN products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0181-Ab-1/ GM-Tg-hg-SE0181-Ab-2Anti-Human EPGN monoclonal antibodyHuman
GM-Tg-rg-SE0181-Ab-1/ GM-Tg-rg-SE0181-Ab-2Anti-Rat EPGN monoclonal antibodyRat
GM-Tg-mg-SE0181-Ab-1/ GM-Tg-mg-SE0181-Ab-2Anti-Mouse EPGN monoclonal antibodyMouse
GM-Tg-cynog-SE0181-Ab-1/ GM-Tg-cynog-SE0181-Ab-2Anti-Cynomolgus/ Rhesus macaque EPGN monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0181-Ab-1/ GM-Tg-felg-SE0181-Ab-2Anti-Feline EPGN monoclonal antibodyFeline
GM-Tg-cang-SE0181-Ab-1/ GM-Tg-cang-SE0181-Ab-2Anti-Canine EPGN monoclonal antibodyCanine
GM-Tg-bovg-SE0181-Ab-1/ GM-Tg-bovg-SE0181-Ab-2Anti-Bovine EPGN monoclonal antibodyBovine
GM-Tg-equg-SE0181-Ab-1/ GM-Tg-equg-SE0181-Ab-2Anti-Equine EPGN monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0181-Ab-1/ GM-Tg-hg-SE0181-Ab-2; GM-Tg-rg-SE0181-Ab-1/ GM-Tg-rg-SE0181-Ab-2;
GM-Tg-mg-SE0181-Ab-1/ GM-Tg-mg-SE0181-Ab-2; GM-Tg-cynog-SE0181-Ab-1/ GM-Tg-cynog-SE0181-Ab-2;
GM-Tg-felg-SE0181-Ab-1/ GM-Tg-felg-SE0181-Ab-2; GM-Tg-cang-SE0181-Ab-1/ GM-Tg-cang-SE0181-Ab-2;
GM-Tg-bovg-SE0181-Ab-1/ GM-Tg-bovg-SE0181-Ab-2; GM-Tg-equg-SE0181-Ab-1/ GM-Tg-equg-SE0181-Ab-2
Products NameAnti-EPGN monoclonal antibody
Formatmab
Target NameEPGN
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody, Cytokine antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-EPGN benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0181-Ag-1Recombinant multi-species EPGN/ ALGV3072/ EPG protein
    CytokineGM-Tg-g-SE0181-Ag-1epithelial mitogen (EPGN) protein


    Target information

    Target IDGM-SE0181
    Target NameEPGN
    Gene ID255324,71920,289515,702632,611937,101081293,100295331,100050376
    Gene Symbol and Synonyms2310069M11Rik,ALGV3072,EPG,EPGN,epigen,PRO9904,RGD1560084
    Uniprot AccessionQ6UW88
    Uniprot Entry NameEPGN_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    CategoryCytokine Target
    DiseaseN/A
    Gene EnsemblENSG00000182585
    Target ClassificationN/A

    The target: EPGN, gene name: EPGN, also named as ALGV3072, EPG, PRO9904. The protein encoded by this gene is a member of the epidermal growth factor family. Members of this family are ligands for the epidermal growth factor receptor and play a role in cell survival, proliferation and migration. This protein has been reported to have high mitogenic activity but low affinity for its receptor. Expression of this transcript and protein have been reported in cancer specimens of the breast, bladder, and prostate. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2012].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.